Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04739228
Other study ID # GDP_2016
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2017
Est. completion date March 1, 2020

Study information

Verified date February 2021
Source European University of Rome
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

We conducted a randomized-controlled trial of Guided Written Disclosure Protocol for dermatological patients with the aim of reducing psychological distress, expressive suppression, and skin-related symptoms, and improving spiritual well-being, cognitive reappraisal, and sense of coherence.


Description:

Sample size assessment: A recent meta-analysis reported a study which showed that Guided Written Disclosure Protocol reach on effect size of 0.89 on psychosocial outcomes (Gidron et al., 2002; Mogk et al., 2006). Power analysis showed that with an alpha of 0.05 and a power of 0.80, we needed a sample of 34 participants to detect effect sizes of 0.89 and higher. Plan for missing data: Occasional missing values were imputed by calculating, for each participant, the average score for each subscale and then replaced. Statistical analysis plan: We conducted a 2 (group) X 2 (time [pre-treatment vs. post-treatment]) repeated measures multivariate analysis of variance (MANOVA) for a set of variables.


Recruitment information / eligibility

Status Completed
Enrollment 45
Est. completion date March 1, 2020
Est. primary completion date March 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Age over 18 years; - Diagnosis of psoriasis or systemic sclerosis by a board-certified dermatologist. Exclusion Criteria: - Patients with certified mental disorders (e.g., psychotic illness, major depressive disorder) - Patients undergoing psychotherapy for at least 6 months in the last 3 years; - Patients who currently receive psychopharmacological treatment.

Study Design


Intervention

Behavioral:
Guided Written Disclosure Protocol Group
The writing task consists of three sessions of 20 minutes each, with an interval of one week between each other. In the first session, patients were asked to describe the onset of illness, describing chronologically and detailed places, images, sounds and actions, as they are followed and detached from the emotions. In the second session, the patients were asked to write about thoughts and emotions felt during the illness experience, talking about the impact that illness had on their daily lives and how it had changed their personal attitude to life itself. In the third and final session, the patients were asked to analyze subjective new skills acquired.
Active Control Group
The writing task also consists of three sessions of 20 minutes each, with an interval of one week between each other. In all three writing sessions, patients were asked to report the daily activities during the last week, without focusing on the emotional aspects.

Locations

Country Name City State
Italy IRCSS Istituto Dermopatico dell'Immacolata, Fondazione Luigi Maria Monti Rome

Sponsors (2)

Lead Sponsor Collaborator
European University of Rome IRCSS Istituto Dermopatico dell'Immacolata, Fondazione Luigi Maria Monti

Country where clinical trial is conducted

Italy, 

References & Publications (2)

Gidron Y, Duncan E, Lazar A, Biderman A, Tandeter H, Shvartzman P. Effects of guided written disclosure of stressful experiences on clinic visits and symptoms in frequent clinic attenders. Fam Pract. 2002 Apr;19(2):161-6. — View Citation

Mogk C, Otte S, Reinhold-Hurley B, Kröner-Herwig B. Health effects of expressive writing on stressful or traumatic experiences - a meta-analysis. Psychosoc Med. 2006 Nov 16;3:Doc06. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change from Pre-test to Post-test and Follow-up in Spiritual Well-Being, which will be reported in the outcome measure results data table as means and standard deviations. Spiritual well-being will be measured with the FACIT-Sp (minimum value=0; maximum value=48, with higher scores indicating a better outcome), a questionnaire assessing faith, peace and meaning Pre-Test (before the intervention), Post-Test (30 days after the baseline assessment)
Primary Change from Pre-test to Post-test and Follow-up in Psychological Distress, which will be reported in the outcome measure results data table as means and standard deviations. Psychological distress will be measured with the GHQ-12 (minimum value=1; maximum value=4, with higher score indicating greater outcome). Pre-Test (before the intervention), Post-Test (30 days after the baseline assessment)
Secondary Change from Pre-test to Post-test and Follow-up in Emotion Regulation, which will be reported in the outcome measure results data table as means and standard deviations. Emotion regulation will be measured with ERQ (minimum value=1; maximum value=7), a questionnaire assessing expressive suppression and cognitive reappraisal. Pre-Test (before the intervention), Post-Test (30 days after the baseline assessment)
Secondary Change from Pre-test to Post-test and Follow-up in Skin-related Quality of Life, which will be reported in the outcome measure results data table as means and standard deviations. Skin-related Quality of Life will be measured with Skindex 29 (minimum value=1; maximum value=5, with higher score indicating a worse outcome), a questionnaire assessing symptoms, emotions, and functioning. Pre-Test (before the intervention), Post-Test (30 days after the baseline assessment)
Secondary Change from Pre-test to Post-test and Follow-up in Sense of Coherence, which will be reported in the outcome measure results data table as means and standard deviations. Sense of Coherence will be measured with SOC-13 (minimum value=1; maximum value=7, with higher score indicating a greater outcome), a questionnaire assessing comprehensibility and meaningfulness of human experience Pre-Test (before the intervention), Post-Test (30 days after the baseline assessment)
See also
  Status Clinical Trial Phase
Recruiting NCT04680611 - Severe Asthma, MepolizumaB and Affect: SAMBA Study
Completed NCT05130944 - Feasibility of Community Psychosocial Intervention for Women N/A
Recruiting NCT05526235 - A Scalable Psychological Intervention to Reduce Psychological Distress Among Workers of Assisted Living Facilities N/A
Recruiting NCT05413941 - Internet-based Cognitive Behavioral Therapy in Inflammatory Bowel Disease N/A
Completed NCT03720600 - Forms of Racial Discrimination Study N/A
Not yet recruiting NCT05400096 - Psychological Wellbeing in Clients in Tier 3 Weight Management Service N/A
Completed NCT02212236 - Psychological Intervention for Distress During HSCT Phase 2
Active, not recruiting NCT00892138 - Mindfulness Training for Stress Management N/A
Recruiting NCT04936828 - Ecological Momentary Intervention for Stroke Caregivers' Psychological Support N/A
Recruiting NCT04815278 - NC Works4Health: Reducing Chronic Disease Risks in Socioeconomically Disadvantaged, Unemployed Populations N/A
Withdrawn NCT03341364 - Acceptance and Commitment Based Group Therapy for Cancer Patients N/A
Recruiting NCT05137925 - Mindful Moms: Mechanisms of Mindfulness-based Cognitive Therapy During Pregnancy and Postpartum N/A
Completed NCT04376723 - Mental Health Apps for Mild Psychological Distress Amongst Adolescents N/A
Active, not recruiting NCT04020497 - Ensemble Programme an Early Intervention for Informal Caregivers of Psychiatric Patients N/A
Not yet recruiting NCT03652168 - Stress Free UC Merced: The Effect of 8 Weeks of Mindfulness App Headspace on Stress in a Sample of University Employees Phase 3
Terminated NCT03587896 - Implementation of Self Help Plus in Adult Syrian Refugees in Turkey (RE-DEFINE) N/A
Completed NCT03721770 - Psychological Impact in a Relative, Following the Announcement of the Death of a Loved One After Cardiac Arrest and the Early Request for Organ Donation
Recruiting NCT05849454 - Messy Memories: Mobile Application Therapy Following Critical Illness N/A
Recruiting NCT05525299 - Reminiscence-Based Life Review on Copying With Existential Suffering Among Older Cancer Survivors N/A
Recruiting NCT06052904 - Music Breathing for Caregivers of Children Newly Diagnosed With Cancer N/A